eli lilly's tirzepatide is the leader in weight loss sector Lilly drug data released Tirzepatide from Lilly may be
Description
Zepbound: For adults with obesity (BMI 30) or who are overweight (BMI 27) with at least one weight-related health condition like high blood pressure or high cholesterol
10.2337/dc11-s231 16 GarveyW
Age, baseline HbA1c and fasting plasma glucose were very similar in the semaglutide 1mg arm of the SURPASS2 refined population (refined on HbA1c inclusion criterion of 8.0%10.0%) and the SUSTAIN FORTE full population (Table 2)
These are not official guidelines
